XML 65 R9.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
OPERATING ACTIVITIES:      
Net income (loss) $ (777) $ 762 $ 1,147
Adjustments to net income:      
Depreciation and amortization 1,176 1,144 1,245
Gain on sales and disposals of businesses (29) (29) (358)
Impairment expenses 1,098 602 383
Deferred income taxes (793) (50) 47
Provisions for (reversals of) contingencies 48 (72) (34)
Loss on extinguishment of debt 20 186 261
Loss (Gain) on sale and disposal of assets 38 20 (20)
Impairments of discontinued operations and held-for-sale businesses (1,383) 0 (50)
Other 168 8 92
Changes in operating assets and liabilities:      
(Increase) decrease in accounts receivable 237 (378) (520)
(Increase) decrease in inventory 42 (26) (48)
(Increase) decrease in prepaid expenses and other current assets 870 655 (73)
(Increase) decrease in other assets (251) (1,305) (723)
Increase (decrease) in accounts payable and other current liabilities (620) 31 (85)
Increase (decrease) in income tax payables, net and other tax payables (199) 53 (89)
Increase (decrease) in other liabilities 473 533 516
Net cash provided by operating activities 2,884 2,134 1,791
INVESTING ACTIVITIES:      
Capital expenditures (2,345) (2,308) (2,016)
Acquisitions, net of cash acquired (55) (17) (728)
Proceeds from the sale of businesses, net of cash sold, and equity method investments 631 138 1,807
Sale of short-term investments 4,904 4,851 4,503
Purchase of short-term investments (5,151) (4,801) (4,623)
(Increase) decrease in restricted cash, debt service reserves and other assets (61) (159) 419
Other investing (31) (70) (18)
Net cash used in investing activities (2,108) (2,366) (656)
FINANCING ACTIVITIES:      
Borrowings under the revolving credit facilities 1,465 959 836
Repayments under the revolving credit facilities (1,433) (937) (834)
Issuance of recourse debt 500 575 1,525
Repayments of recourse debt (808) (915) (2,117)
Issuance of non-recourse debt 2,978 4,248 4,179
Repayments of non-recourse debt (2,666) (3,312) (3,481)
Payments for financing fees (105) (90) (158)
Distributions to noncontrolling interests (476) (326) (485)
Contributions from noncontrolling interests and redeemable security holders 190 126 143
Proceeds from the sale of redeemable stock of subsidiaries 134 461 0
Dividends paid on AES common stock (290) (276) (144)
Payments for financed capital expenditures (113) (150) (528)
Purchase of treasury stock (79) (482) (308)
Proceeds from sales to noncontrolling interests, net of transaction costs 0 154 83
Other financing (44) (7) 27
Net cash (used in) provided by financing activities (747) 28 (1,262)
Effect of exchange rate changes on cash 9 (52) (51)
Decrease (Increase) in cash of discontinued operations and held-for-sale businesses 10 (4) 59
Total Increase (decrease) in cash and cash equivalents 48 (260) (119)
Cash and cash equivalents, beginning 1,257 1,517  
Cash and cash equivalents, ending 1,305 1,257 1,517
SUPPLEMENTAL DISCLOSURES:      
Cash payments for interest, net of amounts capitalized 1,273 1,265 1,351
Cash payments for income taxes, net of refunds 487 388 480
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:      
Assets received upon sale of subsidiaries 0 0 44
Assets acquired through capital lease and other liabilities 5 18 49
Dividends declared but not yet paid $ 174 $ 135 $ 72